Aethlon Medical logo
Aethlon Medical AEMD
$ 3.4 0.0%

Quarterly report 2025-Q3
added 11-12-2025

report update icon

Aethlon Medical Financial Statements 2011-2025 | AEMD

Annual Financial Statements Aethlon Medical

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

3.03 M 182 K 863 K 6.2 M 12.1 M 4.78 M 13.8 M 16.5 M 17.3 M 35.9 M 45.6 M 40.8 M 16.4 M 11.2 M 6.26 M

Shares

1.56 M 314 K 2.05 M 14.8 M 12.1 M 3.41 M 1.21 M 821 K 518 K 493 K 373 K 259 K 199 K 136 K 92.8 K

Historical Prices

1.94 0.58 0.42 0.42 1.32 2.2 2.73 14.7 22.6 56.5 72.2 142 128 67.5 90

Net Income

-13.4 M -12.2 M -12 M -10.4 M -7.89 M -6.37 M -6.19 M -5.68 M -7.28 M -4.87 M -6.8 M -13.4 M -4.89 M -8.11 M -5.71 M

Revenue

- - 574 K 294 K 659 K 650 K 230 K 150 K 392 K 887 K 762 K 1.62 M 1.23 M 1.36 M -

Cost of Revenue

3.87 M 5.21 M 4.44 M 4.63 M 3.45 M 2.3 M 3.08 M 2.63 M 3.48 M 2.08 M 2.28 M 2.23 M 2.17 M 2.05 M 2.9 M

Gross Profit

- - - - - - - - - - - - - 1.36 M -

Operating Income

-9.34 M -12.6 M -11.9 M -10.4 M -7.89 M -5.93 M -6 M -4.83 M -6.1 M -4.38 M -3.99 M -3.06 M -3.58 M -3.11 M -4.56 M

Interest Expense

10.1 K - - - - - - - - - 350 K 1.29 M - - -

EBITDA

-9 M -12.3 M -11.7 M -10.3 M -7.85 M -5.9 M -5.97 M -4.8 M -6.07 M -4.35 M -3.96 M -3.03 M -3.56 M -3.1 M -4.54 M

Operating Expenses

9.34 M 12.6 M 12.5 M 10.7 M 8.55 M 6.58 M 6.23 M 4.98 M 6.49 M 5.27 M 4.76 M 4.68 M 4.81 M 4.47 M 4.56 M

General and Administrative Expenses

3.24 M 3.9 M 4.48 M 3.46 M 2.46 M 6.58 M 6.23 M 4.98 M 6.49 M 5.27 M 4.76 M 4.68 M 4.81 M 4.47 M 4.56 M

All numbers in USD currency

Quarterly Income Statement Aethlon Medical

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

398 K 2.08 M 259 K 14 M 174 K 932 K 2.63 M 2.52 M 2.48 M 2.43 M 2.3 M 2.29 M 2.07 M 15.5 M 15.4 M 15.4 M 14.5 M 14.1 M 15.4 M 12.1 M 12.1 M 12.1 M 9.63 M 2.89 M 2.89 M 1.32 M 19.1 M 1.2 M 18.1 M 17.8 M 17.7 M 15 M 9.03 M 8.81 M 8.8 M 7.93 M 7.77 M 7.69 M 7.62 M 7.62 M 7.32 M 7.17 M 6.66 M 6.03 M 259 M 227 M 4.5 M 198 M 188 M 182 M 174 M 159 M 143 M 135 M 118 M 107 M 98.2 M 93.8 M 77.5 M

Net Income

-1.49 M -1.76 M - -1.75 M -2.81 M -2.57 M - -3.47 M -3.03 M -3.28 M - -2.85 M -3.81 M -2.91 M - -2.53 M -6.63 M -2.1 M - -2.44 M -5.62 M -1.77 M -1.41 M -820 K -820 K -1.71 M -2.07 M -2.01 M -2.01 M -1.39 M - -1.22 M -1.3 M -1.84 M - -1.21 M -5.59 M -4.38 M - -1.22 M -3.62 M -2.41 M - -1.55 M -5.91 M -4.5 M - -2.23 M -5.88 M -3.65 M - 314 K -2.13 M -2.44 M - -575 K -3.61 M -3.04 M -

Revenue

- - - - - - - - - - - - - - - 17.1 K 281 K 264 K - 625 K 625 K - - 413 K 413 K - 30 K - - - - 74.8 K - - - - 392 K 4.64 K - - - - - 33.4 K 479 K 51.3 K - 76.3 K 917 K 840 K - 209 K 826 K 617 K - 958 K 958 K - -

Cost of Revenue

595 K 581 K - 620 K 1.37 M 1.25 M - 1.92 M 1.19 M 1.12 M - 1.05 M 1.11 M 1.03 M - 1 M 2.82 M 1.82 M - 1.52 M 1.52 M 560 K 437 K 406 K 406 K 598 K 606 K 1.16 M 1.16 M 672 K - 663 K 618 K 630 K - 636 K 2.79 M 2.16 M - 615 K 1.67 M 1.06 M - 571 K 1.74 M 1.17 M - 425 K 1.29 M 863 K - 507 K 1.62 M 1.11 M - 488 K 1.55 M 1.07 M -

Operating Income

-1.51 M -1.79 M - -1.81 M -2.9 M -2.62 M - -3.57 M -3.18 M -3.41 M - -2.85 M -3.67 M -2.91 M - -2.53 M -6.64 M -4.11 M - -2.44 M -2.44 M -1.77 M -1.41 M -876 K -876 K -1.7 M -1.57 M -1.96 M -1.96 M -1.35 M - -1.16 M -1.24 M -1.16 M - -1.24 M -4.59 M -3.36 M - -1.08 M -3.3 M -2.21 M - -1.09 M -2.86 M -1.77 M - -1.23 M -2.25 M -1.01 M - -937 K -2.73 M -1.79 M - -341 K -2.26 M -1.92 M -

Interest Expense

22.7 K -5.93 K - - 95.1 K - - - - - - - - - - - - 125 - - - 728 - - 54 K 54 K - - - - - - - 189 K - - 113 K 77.4 K - - 400 K 252 K - - - 78.7 K - - 330 K 217 K - - - 25 K - - 360 K 360 K -

EBITDA

- -1.71 M - - - -2.53 M - - - -3.32 M - -2.85 M -3.5 M -2.88 M - -2.53 M -6.54 M -4.03 M - -2.44 M -2.41 M -1.75 M -1.4 M -876 K -860 K -1.7 M -1.56 M -1.96 M -1.94 M -1.33 M - -1.16 M -1.24 M -1.15 M - -1.24 M -4.57 M -3.34 M - -1.08 M -3.27 M -2.2 M - -1.09 M -2.83 M -1.76 M - -1.23 M -2.23 M -1.01 M - -937 K -2.72 M -1.79 M - -341 K -2.24 M -1.91 M -

Operating Expenses

1.51 M 1.79 M - 1.81 M 2.9 M 2.62 M - 3.57 M 3.18 M 3.41 M - 2.85 M 3.67 M 2.91 M - 2.55 M 6.92 M 4.37 M - 3.07 M 3.07 M 1.77 M 1.41 M 1.29 M 1.29 M 1.7 M 1.6 M 1.96 M 1.96 M 1.35 M - 1.24 M 1.24 M 1.16 M - 1.24 M 4.99 M 3.75 M - 1.39 M 3.98 M 2.6 M - 1.12 M 3.42 M 2.3 M - 1.31 M 3.16 M 1.85 M - 1.15 M 3.55 M 2.41 M - 1.3 M 3.21 M 1.92 M -

General and Administrative Expenses

521 K 735 K - 816 K 958 K 752 K - 979 K 851 K 1.31 M - 1.07 M 1.55 M 1.03 M - 1.11 M 2.43 M 1.32 M - 921 K 920 K 555 K 409 K 274 K 274 K 342 K 383 K 215 K 215 K 272 K - 136 K 235 K 187 K - 183 K 697 K 514 K - 383 K 994 K 612 K - 467 K 896 K 428 K - 330 K 669 K 339 K - 196 K 563 K 367 K - 384 K 624 K 240 K -

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements Aethlon Medical AEMD
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting Aethlon Medical plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Abiomed Abiomed
ABMD
- - $ 17.2 B usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Apyx Medical Corporation Apyx Medical Corporation
APYX
$ 3.86 -3.26 % $ 134 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Bio-Rad Laboratories Bio-Rad Laboratories
BIO
$ 307.92 -1.93 % $ 8.69 B usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 45.13 -2.67 % $ 6.72 K usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Abbott Laboratories Abbott Laboratories
ABT
$ 125.1 1.48 % $ 218 B usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 92.34 0.64 % $ 136 B usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
$ 2.56 8.94 % $ 95.5 M franceFrance
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 17.7 -3.46 % $ 408 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
Xtant Medical Holdings Xtant Medical Holdings
XTNT
$ 0.73 4.33 % $ 97.6 M usaUSA
InMode Ltd. InMode Ltd.
INMD
$ 14.56 0.76 % $ 1.15 B israelIsrael
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
$ 9.88 0.05 % $ 709 M israelIsrael
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
Align Technology Align Technology
ALGN
$ 165.15 0.78 % $ 12.4 B usaUSA
Accuray Incorporated Accuray Incorporated
ARAY
$ 1.07 -3.18 % $ 110 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 12.81 -1.23 % $ 346 M usaUSA
FONAR Corporation FONAR Corporation
FONR
$ 14.86 -0.03 % $ 97.4 M usaUSA
AxoGen AxoGen
AXGN
$ 30.33 1.15 % $ 1.34 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
GBS GBS
GBS
- -0.57 % $ 7.12 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 40.78 2.33 % $ 1.26 B usaUSA
Globus Medical Globus Medical
GMED
$ 86.83 -2.31 % $ 11.8 B usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
$ 13.41 -4.56 % $ 1.03 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
$ 20.04 0.65 % $ 2.86 B usaUSA
Establishment Labs Holdings Establishment Labs Holdings
ESTA
$ 72.58 -0.19 % $ 2.04 B costa-ricaCosta-rica
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 0.92 -4.72 % $ 14.8 M usaUSA
Electromed Electromed
ELMD
$ 29.74 0.64 % $ 251 M usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
$ 96.35 -1.06 % $ 1.22 B usaUSA